ETEPLIRSEN - INJECTION
PHONETIC PRONUNCIATION: (e-TEP-lir-sen)
COMMON BRAND NAME(S): Exondys 51
GENERIC NAME(S): eteplirsen
Uses
USES: Eteplirsen is used to treat a certain inherited muscle disorder (Duchenne muscular dystrophy-DMD). This disorder is caused by a lack of a certain muscle protein (dystrophin). This medication can increase the amount of dystrophin in your body.
How to use ETEPLIRSEN - INJECTION
HOW TO USE: This medication is given by injection into a vein by a health care professional as directed by your doctor. It is usually given once every week over 35 to 60 minutes. The dosage is based on your weight. Tell your doctor if your condition does not get better or if it gets worse.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for ETEPLIRSEN - INJECTION
Eteplirsen is an injectable medication used for the treatment of Duchenne muscular dystrophy (DMD) in patients with a specific genetic mutation.
Eteplirsen works by skipping a particular section of genetic material called exon 51. This helps in the production of a functional form of the dystrophin protein, which is essential for muscle function.
The recommended dosage of Eteplirsen is based on the patient's weight. Generally, a dose of 30 mg/kg is administered once a week as an intravenous infusion over a period of approximately 35 to 60 minutes.
The common side effects of Eteplirsen include injection site reactions, vomiting, and infections of the upper respiratory tract. It is important to discuss any potential side effects with your healthcare provider.
The effects of Eteplirsen on muscle function vary among individuals. Some patients may experience improvements in muscle strength and function within a few weeks or months, while for others, it may take longer to witness significant benefits.
Eteplirsen is not a cure for Duchenne muscular dystrophy. It is a medication that helps slow down the progression of the disease and improve muscle function in patients with specific genetic mutations.
Some precautions and warnings associated with Eteplirsen include the risk of kidney problems, hypersensitivity reactions, and prolongation of the QT interval (a heart rhythm disorder). It is important to discuss your medical history and any current medications with your healthcare provider before starting Eteplirsen.
Yes, Eteplirsen can be used in children with Duchenne muscular dystrophy who have a specific genetic mutation and meet the eligibility criteria determined by their healthcare provider.
While specific drug interactions with Eteplirsen are not well-established, it is always important to inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting Eteplirsen to avoid any potential interactions.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet